咨询热线:

020-3107 8154

ONX-0914 (PR-957) PR-957

ONX-0914 (PR-957)是一种有效的,选择性immunoproteasome抑制剂,无细胞试验中对组成型蛋白酶体具有最低的交叉反应性。

  • 货号:
    TK0522
  • 规格:
    5mg
    10mg
    50mg
  • 价格:
    0.00

产品参数

CAS No.960374-59-8
生物活性ONX-0914 (PR-957) is a selective inhibitor of low-molecular mass polypeptide-7 (LMP7), the chymotrypsin-like subunit of the immunoproteasome. ONX-0914 blocks cytokine production and attenuates progression of experimental arthritis. ONX-0914 is a noncompetitive irreversible inhibitor of the mycobacterial proteasome (Ki=5.2 μM). ONX-0914 reactivates latent HIV-1 through p-TEFb activation mediated by HSF-1.
分子式C31H40N4O7
分子量580.67
运输条件Room temperature in continental US; may vary elsewhere.
储存条件Powder, -20°C ,3 years
溶解性数据DMSO : ≥ 35 mg/mL (60.28 mM)
体内研究ONX-0914 (2-10 mg/kg; i.v,; on days 4, 6 and 8) meliorates disease in mouse arthritis.ONX-0914 (2, 6 and 10 mg per kg body weight on days 25, 27, 29, 31 and 33; i.v.) treatment also induced a rapid therapeutic response in the T and B cell–dependent CIA (collagen-induced arthritis) model.
体外研究ONX-0914 inhibits LMP7-specific antigen presentation. ONX-0914 blocks cytokine productionby mouse splenocytes and blocks T celldifferentiation.
纯度及产品资料98%